Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-582-7956
Summary
- Dr. Prabhsimranjot Singh is an oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Dana-Farber Cancer Institute and Brigham and Women's Hospital.
Education & Training
Maimonides Medical CenterFellowship, Hematology and Medical Oncology, 2014 - 2017- Maimonides Medical CenterResidency, Internal Medicine, 2011 - 2014
Indira Gandhi Medical CollegeClass of 2009
Certifications & Licensure
MA State Medical License 2017 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation Start of enrollment: 2022 Dec 08
- Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease Start of enrollment: 2022 Mar 10
- Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial Start of enrollment: 2020 Jun 16
Publications & Presentations
PubMed
- 22 citationsCesium-131 permanent seed brachytherapy: dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staff.Bhupesh Parashar, A. Gabriella Wernicke, Al Pavese, Prabhsimranjot Singh, Samuel Trichter
Brachytherapy. 2011-11-01 - 120 citationsAnti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancerPrabhsimranjot Singh, Sudhamshi Toom, Yiwu Huang
Journal of Hematology & Oncology. 2017-05-12 - 58 citationsThe Immune Modulation Effect of Locoregional Therapies and Its Potential Synergy with Immunotherapy in Hepatocellular Carcinoma.Prabhsimranjot Singh, Sudhamshi Toom, Akshay Avula, Vivek Kumar, Osama E. Rahma
Journal of Hepatocellular Carcinoma. 2020-02-10
Committees
- Cancer Liason Phsyician, Commission on Cancer 2020 - 2023
Professional Memberships
- Member
- Member
- Member
Other Languages
- Hindi, Punjabi
External Links
- DFCI https://www.dana-farber.org/find-a-doctor/prabhsimranjot-singh
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
